These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1266 related items for PubMed ID: 19995872

  • 1. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [Abstract] [Full Text] [Related]

  • 2. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y, Hayashi T, Yamada M, Okano H, Kawase T.
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [Abstract] [Full Text] [Related]

  • 3. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule.
    Ourednik V, Ourednik J, Xu Y, Zhang Y, Lynch WP, Snyder EY, Schachner M.
    Stem Cells; 2009 Nov; 27(11):2846-56. PubMed ID: 19785036
    [Abstract] [Full Text] [Related]

  • 4. Transplantation of embryonic neural stem/precursor cells overexpressing BM88/Cend1 enhances the generation of neuronal cells in the injured mouse cortex.
    Makri G, Lavdas AA, Katsimpardi L, Charneau P, Thomaidou D, Matsas R.
    Stem Cells; 2010 Jan; 28(1):127-39. PubMed ID: 19911428
    [Abstract] [Full Text] [Related]

  • 5. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ, Sortwell CE, Elsworth JD, Taylor JR, Roth RH, Sladek JR, Redmond DE.
    J Comp Neurol; 2002 Jan 21; 442(4):320-30. PubMed ID: 11793337
    [Abstract] [Full Text] [Related]

  • 6. Tenascin-R promotes neuronal differentiation of embryonic stem cells and recruitment of host-derived neural precursor cells after excitotoxic lesion of the mouse striatum.
    Hargus G, Cui Y, Schmid JS, Xu J, Glatzel M, Schachner M, Bernreuther C.
    Stem Cells; 2008 Aug 21; 26(8):1973-84. PubMed ID: 18499893
    [Abstract] [Full Text] [Related]

  • 7. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
    Falkenstein G, Rosenthal C, Reum T, Morgenstern R, Döbrössy M, Nikkhah G.
    J Comp Neurol; 2009 Jul 01; 515(1):41-55. PubMed ID: 19399892
    [Abstract] [Full Text] [Related]

  • 8. In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.
    Hargus G, Cui YF, Dihné M, Bernreuther C, Schachner M.
    Curr Protoc Stem Cell Biol; 2012 May 01; Chapter 2():Unit 2D.11. PubMed ID: 22605646
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M, Hong M, Mukhida K, Sadi D, Ulalia R, Mendez I.
    Eur J Neurosci; 2006 Jul 01; 24(2):361-70. PubMed ID: 16903847
    [Abstract] [Full Text] [Related]

  • 10. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons.
    Geeta R, Ramnath RL, Rao HS, Chandra V.
    Biochem Biophys Res Commun; 2008 Aug 22; 373(2):258-64. PubMed ID: 18565328
    [Abstract] [Full Text] [Related]

  • 11. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery.
    Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, Hovatta O, Jolkkonen J.
    Eur J Neurosci; 2009 Feb 22; 29(3):562-74. PubMed ID: 19175403
    [Abstract] [Full Text] [Related]

  • 12. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M, Timmer M, Nikkhah G.
    J Neurosci Res; 2009 Jul 22; 87(9):2006-19. PubMed ID: 19235889
    [Abstract] [Full Text] [Related]

  • 13. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease.
    Oizumi H, Hayashita-Kinoh H, Hayakawa H, Arai H, Furuya T, Ren YR, Yasuda T, Seki T, Mizuno Y, Mochizuki H.
    Neurosci Res; 2008 Jan 22; 60(1):15-21. PubMed ID: 17963913
    [Abstract] [Full Text] [Related]

  • 14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
    Inden M, Kim DH, Qi M, Kitamura Y, Yanagisawa D, Nishimura K, Tsuchiya D, Takata K, Hayashi K, Taniguchi T, Yoshimoto K, Shimohama S, Sumi S, Inoue K.
    Neurosci Lett; 2005 Oct 28; 387(3):151-6. PubMed ID: 16023291
    [Abstract] [Full Text] [Related]

  • 16. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
    Chao YX, He BP, Tay SS.
    J Neuroimmunol; 2009 Nov 30; 216(1-2):39-50. PubMed ID: 19819031
    [Abstract] [Full Text] [Related]

  • 17. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
    Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, Blandini F.
    Brain Res; 2010 Jan 22; 1311():12-27. PubMed ID: 19945443
    [Abstract] [Full Text] [Related]

  • 18. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.
    Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY.
    Nat Biotechnol; 2002 Nov 22; 20(11):1103-10. PubMed ID: 12379867
    [Abstract] [Full Text] [Related]

  • 19. Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model.
    Cho YH, Kim DS, Kim PG, Hwang YS, Cho MS, Moon SY, Kim DW, Chang JW.
    Biochem Biophys Res Commun; 2006 Mar 03; 341(1):6-12. PubMed ID: 16412382
    [Abstract] [Full Text] [Related]

  • 20. Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease.
    Xu H, Fan X, Wu X, Tang J, Yang H.
    Biochem Biophys Res Commun; 2005 Jan 07; 326(1):115-22. PubMed ID: 15567160
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 64.